Zimmer Biomet 的投资股份增加，并在 2019 年第四季度报告收益略高于预期。 Zimmer Biomet saw increased investment stakes and reported earnings slightly above estimates in Q4 2019.

Zimmer Bimomet Holdings(ZBH)看到DnB资产管理公司和Hazlett Burt & Watson Inc.在Q4 2019的资产管理公司增加了股份。 Zimmer Biomet Holdings (ZBH) saw increased stakes by asset managers like DnB Asset Management and Hazlett Burt & Watson Inc. in Q4 2019. 设计整形产品的医疗技术公司报告,每股收入为2.31美元,略微超出估计。 The medical tech company, which designs orthopedic products, reported earnings of $2.31 per share, slightly beating estimates. Zimmer Biomet的股价目前为113.33美元,市场上限为225.6亿美元,具有一致的“稳住”评级,每季度支付每股0.24美元的股息,收益率为0.85%。 Zimmer Biomet's stock, currently valued at $113.33 with a market cap of $22.56 billion, has a consensus "Hold" rating and pays a quarterly dividend of $0.24 per share, yielding 0.85%.